共 78 条
[31]
Yoshinaga T(2018)18F-flutemetamol positron emission tomography in cardiac amyloidosis J. Nucl. Cardiol. 25 1132-2412
[32]
Yazaki M(2022)Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis J. Nucl. Cardiol. 29 774-514
[33]
Sekijima Y(2020)18F-fluoride PET/MR in cardiac amyloid: A comparison study with aortic stenosis and age- and sex-matched controls J Nucl Cardiol 27 2404-514
[34]
Genovesi D(2016)18F-sodium fluoride PET/MRI myocardial imaging in patients with suspected cardiac amyloidosis Circulation 133 506-518
[35]
Kircher M(2022)18 F-Sodium Fluoride PET/MR for the Assessment of Cardiac Amyloidosis J Nucll Cardiol 29 506-1626
[36]
Law WP(2022)18Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosis J Nucl Cardiol. 29 515-417
[37]
Wang WYS(2022)Comparison of 18F-sodium fluoride positron emission tomography imaging and 99mTc-pyrophosphate in cardiac amyloidosis J Nucl Cardiol. 29 40-91
[38]
Moore PT(2020)Quantification of 11C-PIB kinetics in cardiac amyloidosis Curr Cardiol Rep. 22 1620-undefined
[39]
Mollee PN(2020)Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis ATVB 40 413-undefined
[40]
Ng ACT(2016)Quantitation of myocardial 99mTc-HMDP uptake with new SPECT/CT cadmium zinc telluride (CZT) camera in patients with transthyretin-related cardiac amyloidosis: Ready for clinical use? Cardiovas Pathol. 25 84-undefined